These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26899980)

  • 1. Tumor targeted delivery of octreotide-periplogenin conjugate: Synthesis, in vitro and in vivo evaluation.
    Zhang HY; Xu WQ; Wang YW; Omari-Siaw E; Wang Y; Zheng YY; Cao X; Tong SS; Yu JN; Xu XM
    Int J Pharm; 2016 Apr; 502(1-2):98-106. PubMed ID: 26899980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octreotide-periplocymarin conjugate prodrug for improving targetability and anti-tumor efficiency: synthesis, in vitro and in vivo evaluation.
    Zhang HY; Xu WQ; Zheng YY; Omari-Siaw E; Zhu Y; Cao X; Tong SS; Yu JN; Xu XM
    Oncotarget; 2016 Dec; 7(52):86326-86338. PubMed ID: 27861145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin receptor-mediated specific delivery of paclitaxel prodrugs for efficient cancer therapy.
    Huo M; Zhu Q; Wu Q; Yin T; Wang L; Yin L; Zhou J
    J Pharm Sci; 2015 Jun; 104(6):2018-2028. PubMed ID: 25820241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
    Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
    Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of octreotide surface density on receptor-mediated endocytosis in vitro and anticancer efficacy of modified nanocarrier in vivo after optimization.
    Su Z; Shi Y; Xiao Y; Sun M; Ping Q; Zong L; Li S; Niu J; Huang A; You W; Chen Y; Chen X; Fei J; Tian J
    Int J Pharm; 2013 Apr; 447(1-2):281-92. PubMed ID: 23396258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ligand density and PEG modification on octreotide-targeted liposome via somatostatin receptor in vitro and in vivo.
    Li H; Yuan D; Sun M; Ping Q
    Drug Deliv; 2016 Nov; 23(9):3562-3572. PubMed ID: 27432585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periplogenin Activates ROS-ER Stress Pathway to Trigger Apoptosis via BIP-eIF2α- CHOP and IRE1α-ASK1-JNK Signaling Routes.
    Yang Y; Liu Y; Zhang Y; Ji W; Wang L; Lee SC
    Anticancer Agents Med Chem; 2021; 21(1):61-70. PubMed ID: 32640963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin receptor-mediated tumor-targeting drug delivery using octreotide-PEG-deoxycholic acid conjugate-modified N-deoxycholic acid-O, N-hydroxyethylation chitosan micelles.
    Huo M; Zou A; Yao C; Zhang Y; Zhou J; Wang J; Zhu Q; Li J; Zhang Q
    Biomaterials; 2012 Sep; 33(27):6393-407. PubMed ID: 22704599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octreotide-modification enhances the delivery and targeting of doxorubicin-loaded liposomes to somatostatin receptors expressing tumor in vitro and in vivo.
    Sun M; Wang Y; Shen J; Xiao Y; Su Z; Ping Q
    Nanotechnology; 2010 Nov; 21(47):475101. PubMed ID: 21030757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide-Mediated Tumor-Targeted Drug Delivery via a Cleavable Doxorubicin-Peptide Conjugate.
    Lelle M; Kaloyanova S; Freidel C; Theodoropoulou M; Musheev M; Niehrs C; Stalla G; Peneva K
    Mol Pharm; 2015 Dec; 12(12):4290-300. PubMed ID: 26524088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two step mechanisms of tumor selective delivery of N-(2-hydroxypropyl)methacrylamide copolymer conjugated with pirarubicin via an acid-cleavable linkage.
    Nakamura H; Etrych T; Chytil P; Ohkubo M; Fang J; Ulbrich K; Maeda H
    J Control Release; 2014 Jan; 174():81-7. PubMed ID: 24269967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting delivery of paclitaxel into tumor cells via somatostatin receptor endocytosis.
    Huang CM; Wu YT; Chen ST
    Chem Biol; 2000 Jul; 7(7):453-61. PubMed ID: 10903942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octreotide-mediated tumor cell uptake and intracellular pH-responsive drug delivery of the self-assembly supramolecular nanocarrier.
    Niu J; Huang A; Xiao Y; Su Z; Li H; Ping Q; Bao X; Li S; Chen Y; Sun M
    J Drug Target; 2013 May; 21(5):415-26. PubMed ID: 23597028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and therapeutic evaluation of an aptide-docetaxel conjugate targeting tumor-associated fibronectin.
    Kim H; Lee Y; Lee IH; Kim S; Kim D; Saw PE; Lee J; Choi M; Kim YC; Jon S
    J Control Release; 2014 Mar; 178():118-24. PubMed ID: 24462899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel-octreotide conjugates in tumor growth inhibition of A549 human non-small cell lung cancer xenografted into nude mice.
    Shen H; Hu D; Du J; Wang X; Liu Y; Wang Y; Wei JM; Ma D; Wang P; Li L
    Eur J Pharmacol; 2008 Dec; 601(1-3):23-9. PubMed ID: 18983839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine.
    Su Z; Niu J; Xiao Y; Ping Q; Sun M; Huang A; You W; Sang X; Yuan D
    Mol Pharm; 2011 Oct; 8(5):1641-51. PubMed ID: 21770405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A validated LC-MS/MS method for determination of periplogenin in rat plasma and its application in pharmacokinetic study.
    Bo F; Dou T; Wang X; Donkor PO; Ouyang H; Chang Y; Tu Y; Gao X; He J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 May; 990():80-3. PubMed ID: 25864008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periplogenin induces necroptotic cell death through oxidative stress in HaCaT cells and ameliorates skin lesions in the TPA- and IMQ-induced psoriasis-like mouse models.
    Zhang WJ; Song ZB; Bao YL; Li WL; Yang XG; Wang Q; Yu CL; Sun LG; Huang YX; Li YX
    Biochem Pharmacol; 2016 Apr; 105():66-79. PubMed ID: 26850986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octreotide-conjugated PAMAM for targeted delivery to somatostatin receptors over-expressed tumor cells.
    Peng J; Qi X; Chen Y; Ma N; Zhang Z; Xing J; Zhu X; Li Z; Wu Z
    J Drug Target; 2014 Jun; 22(5):428-38. PubMed ID: 24437350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of biodegradable PCL/PEG nanoparticles for neuroendocrine tumor targeted delivery of somatostatin analog.
    Dubey N; Varshney R; Shukla J; Ganeshpurkar A; Hazari PP; Bandopadhaya GP; Mishra AK; Trivedi P
    Drug Deliv; 2012 Apr; 19(3):132-42. PubMed ID: 22428685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.